Other NYQ
Emergent BioSolutions Inc. (EBS)
Other · Healthcare · Drug Manufacturers - Specialty & Generic
EBS
6.44-0.37 -5.43%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- EBS
- Exchange
- NYQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $330.2M
- Employees
- 900
- Currency
- USD
- Website
- https://www.emergentbiosolutions.com
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the…
Latest coverage
- Emergent BioSolutions: 3 Key Takeaways for Long-Term Investors
November 3, 2026